FDA could erase OTC exemption from device identifier rule

02/11/2013 | Clinica (subscription required)

Over-the-counter medical technologies might not be excluded from the unique device identifier rule being prepared for publication in June by the FDA. "There's a lot of interest in not seeing this exemption in the final rule, so we're taking this into account," said Jay Crowley, senior adviser on patient safety for the FDA.

View Full Article in:

Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ